Major indices worldwide rose on Monday with President Biden’s proposed $1.9 trillion stimulus package in focus. Lawmakers from both parties are lobbying for a targeted relief bill. Futures: The Dow futures are up by 0.13%, and the S&P 500 futures are trading higher by 0.31% on the last check Monday. WTI crude futures are up by 0.63% to $52.60, while gold futures are trading lower by 0.24% at $1,851.80. Ten-year Treasury yield is flat at 1.091%. The VIX futures are down by 1.71% to 24.45. Cryptocurrency: Bitcoin is trading higher by 1.7% at $33,264 on the last check, and Ethereum is up 4.83% at $1,408.45. Ethereum hit an all-time high of $1,480, and several other decentralized finance-based cryptocurrencies hit their all-time highs late Sunday in tandem. Asia: Japan’s Nikkei 225 closed higher by 0.67%, driven by pharma and power stocks. Bank of Japan’s policy-setting meeting minutes is due to release today. China’s Shanghai Composite index gained 0.48%, as China overtook the U.S. as the world’s leading destination for foreign direct investment. Consumer and material stocks drove the index higher. Australia’s S&P/ASX 200 closed higher by 0.36%, as Australia’s Therapeutic Goods Administration approved the COVID-19 vaccine made by Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX). Hong Kong’s Hang Seng rallied 2.41%, led by mainland investor buying. Tech stocks saw the most buying, with Tencent Holdings (OTC: TCEHY) leading the pack gaining 10.93%, followed by Geely Automobile Holding (OTC: GELYY) rising 5.6%. India’s Nifty 50 index is trading lower by 0.53%, driven by a fall in energy and infrastructure stocks. South Korea’s KOSPI rallied 2.18% as consumer and tech stock gains pushed the index higher. The nation’s Q4 GDP is due to release today. Europe: Euro Stoxx 50 is trading marginally higher by 0.05% at press time, with European Central Bank (ECB) President Christine Lagarde’s speech in focus. London’s FTSE 100 is trading lower by 0.07% at publication time. Airline stocks fell on Monday, with International Consolidated Airlines Group (OTC: ICAGY) shedding 6.9% on the last check. Germany’s DAX is down by 0.05% at press time after starting the day in the green. The nation’s business climate index for January fell to 90.1, missing the consensus of 91.8. France’s CAC 40 is trading down by 0.22%, led by financials and industrial stocks. Airbus SE (OTC: EADSY) is down 2.4% in Paris on the last check. Spain’s IBEX 35 is down 0.52% at publication time. Forex Trading: U.S. Dollar Index futures are up 0.04% to 90.248. The dollar has strengthened by 0.10% against the Euro, 0.07% against the Sterling Pound, and 0.02% against the Japanese Yen, but lost 0.02% against the Chinese Yuan. For news coverage in Italian or Spanish, check out Benzinga Italia and Benzinga España. © 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
RALEIGH, N.C.--(BUSINESS WIRE)--Vontier Corporation (“Vontier”) (NYSE: VNT) announced today that it will webcast its earnings conference call for the fourth quarter 2020 on Thursday, February 11, 2021 beginning at 8:00 a.m. ET. The earnings call and an accompanying slide presentation will be webcast on the "Investors" section of Vontier’s website, www.vontier.com, under "Events & Presentations." A replay of the webcast will be available at the same location after the conclusion of the presentation. You can access the conference call by dialing +1 833-614-1510 within the U.S. or +1 918-922-6514 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Vontier’s earnings conference call (access code 2491779). A replay of the conference call will be available shortly after the conclusion of the call. You can access the conference call replay under the Investors / Events and Presentations section of www.vontier.com or by dialing +1 855-859-2056 within the U.S. or +1 404-537-3406 outside the U.S. (access code 2491779). Vontier’s earnings press release, the webcast slides and other related presentation materials will be posted to the "Investors" section of Vontier’s website under "Quarterly Results.” Vontier is now in its “quiet period.” This quiet period will be in place until fiscal fourth quarter 2020 earnings are released on February 11, 2021. During this time, Vontier will not be interacting with the investment community. ABOUT VONTIER Vontier is a global industrial technology company focused on transportation and mobility solutions. The company’s portfolio of trusted brands includes market-leading expertise in mobility technologies, retail and commercial fueling, fleet management, telematics, vehicle diagnostics and repair, and smart cities end-markets. Vontier’s innovative products, services, and software advance efficiency, safety, security, and environmental compliance worldwide. Guided by the proven Vontier Business System and an unwavering commitment to continuous improvement and customer success, Vontier keeps traffic flowing through more than 90,000 intersections, serves more than 260,000 customer fueling sites, monitors more than 480,000 commercial vehicles, and equips over 600,000 auto technicians worldwide. Vontier’s history of innovation, margin profile, and cash flow characteristics are expected to support continued investment across a spectrum of compelling organic and capital deployment growth opportunities. Vontier is mobilizing the future to create a better world.
SAN DIEGO, Jan. 27, 2021 /PRNewswire/ -- Sony Electronics Inc. announces the launch of KOOV Academy in partnership with UC San Diego Education Studies Department. This program supports educators as they implement STEAM (Science, Technology, Engineering, Arts and Math) programs in the...
On the 29th of July 2020, the CEOs of four of the biggest tech companies in the world were called to testify before the...
In an effort to help medical researchers develop new treatments and cures for blinding eye diseases, Advancing Sight Network and Kailos Genetics created the OcularGeneScreen®, a new genetic screening panel, to be used with eye tissue from post-mortem eye donors. The screening will help determine which genes are associated with eye diseases like age-related macular degeneration (AMD), glaucoma, and Fuch's Dystrophy. "These diseases cause a huge decline in quality of life for so many people," says Dr. Gregory Grossman, Advancing Sight Network's Chief Scientific Officer. "By identifying the genes involved, we're taking a huge step forward in being able to find cures." Advancing Sight Network is a nonprofit organization that has served Alabama for more than 50 years. In addition to providing eye tissue for corneal transplants, the organization created the Precision Ocular Biobank in 2019 to invest in medical research. "Our goal is to restore eyesight," says Dr. Grossman. "For the grandparent who can no longer see their grandchild's face or the person who's lost their independence due to incurable vision loss, the development of a cure brings hope for a bright future." Kailos Genetics, a biotechnology company based in Huntsville, provides innovative genetic screenings that help people determine their risk for certain diseases like cancer. IndustryWired recently named Kailos Genetics one of the top 8 precision medicine companies in the USA. "Our mission is to enable clinical research teams to make advances that impact the health of individuals," says Troy Moore, Chief Scientific Officer for Kailos Genetics. "Kailos' TargetRich™ assay development platform combines flexible design and rapid development with the unparalleled insights gained from deep sequencing." The research is funded by a generous grant from the Huntsville-based Alpha Foundation, whose goal is to improve the human condition through grants to educational, scientific and charitable organizations. The bottom line, says Dr. Grossman, is finding cures and making them available as quickly as possible. "We want to help people see again. We want the person who is diagnosed with AMD to have hope. We don't want anyone to lose their livelihood or their independence because of vision loss. Ultimately, that's what this project is about." Not only will the project potentially help over 150,000 people in Alabama who are affected by irreversible vision loss, these two Alabama organizations could be part of bringing cures to more than 200 million people worldwide affected by these diseases. Contact: Candice Lee, [email protected] SOURCE Advancing Sight Network Related Links https://advancingsight.org
USD - United States Dollar